RxDoctor Payments Data

Ryan Rebowe, MD

Plastic Surgery · Mobile, ALNPI 1508203456

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,000 of the $24,322 with a category attached, or 61.7%. Bimini Technologies LLC accounts for 78.4% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $19,517, more than ten times the $1,359 reported in 2019. Among plastic surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,322in general payments, 2019–2025

Across 132 payments — averaging $184.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bimini Technologies LLC$19K
  • Musculoskeletal Transplant Foundation Inc.$1K
  • Mentor Worldwide LLC$1K
  • AbbVie$578
  • Merz North America, Inc.$377
  • Sientra, Inc.$279
  • plus $2K from 25 others

What the payments were for

  • Consulting fees$2,82512%
  • Speaking & faculty fees$15,00062%
  • Travel & lodging$2,2099%
  • Food & beverage$4,28818%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,322 in reported general payments places this provider in the 95th percentile of 35 plastic surgery providers in Alabama.

See all plastic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$32,711
Medicare patients
49
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil49$368
Oxycodone Hcl54$302
Ondansetron OdtOndansetron33$267

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →